Unauthorized Use of Content on this Site: The responses, guidance, and advisories provided by the Pharmaceutical Advertising Advisory Board (PAAB)—including, but not limited to, those available through the PAAB Forum, the PAAB website, and any PAAB correspondence—are specifically intended to assist individuals navigating the PAAB preclearance system. Repurposing or reproducing this content, or using it for model training or any related purposes, is strictly prohibited without the express prior written consent of PAAB. This includes, but is not limited to, the use of such materials in automated systems, machine learning models, or artificial intelligence applications.
76 - Can you please clarify if there are any differences in terms of the PAAB review of an NOC/c product vs a product with full NOC?
-
Health Canada has advised the PAAB to be cautious about approving advertising for products approved as Notice of Compliance with Conditions (NOC/C). There are some special conditions. Health Canada has approved the guideline that the PAAB has posted on the PAAB web-site https://www.paab.ca/Guidance_on_Advertising_for_Drugs_with_Notice_of_Compliance_with_Conditions_(NOCc)Feb_2018(typofix)_docx.pdf You can access that web page for full details.
